Management of multiple myeloma during COVID-19 pandemic Journal Article


Authors: Jethava, Y. S.; Fonseca, R.; Landgren, O.
Article Title: Management of multiple myeloma during COVID-19 pandemic
Abstract: At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019. © 2020
Keywords: cancer recurrence; disease classification; pathophysiology; multiple myeloma; autologous stem cell transplantation; high risk patient; patient care; interleukin 6; world health organization; social distance; pandemic; human; priority journal; article; severe acute respiratory syndrome coronavirus 2; coronavirus disease 2019; case fatality rate
Journal Title: Leukemia Research Reports
Volume: 14
ISSN: 2213-0489
Publisher: Elsevier Inc.  
Date Published: 2020-01-01
Start Page: 100212
Language: English
DOI: 10.1016/j.lrr.2020.100212
PROVIDER: scopus
PMCID: PMC7293439
PUBMED: 32704473
DOI/URL:
Notes: Article -- Export Date: 3 August 2020 -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Carl Ola Landgren
    265 Landgren